Bacteriophage therapy and phage-derived proteins: Dual strategies against antimicrobial resistance and for diagnostic innovation

Event Description

This 3-day, in-person postgraduate course and hands-on technical workshop offers a theoretical and practical introduction to bacteriophage therapy as an emerging solution to antimicrobial resistance (AMR). Drawing on Georgia’s decades of clinical experience—one of the few countries with a long-standing tradition of phage application—the course presents real-world insights into treating bacterial infectious diseases. Participants will engage in a dynamic program featuring lectures, interactive case discussions, and laboratory-based workshops, delivered by a diverse team of Georgian and international experts and professionals. The curriculum also includes comparative perspectives from other countries pioneering phage-based innovations, equipping attendees with the tools to integrate phage therapy into both clinical and research environments.By the end of the course, participants will gain the clinical confidence and scientific understanding needed to apply phage-based solutions in the fight against AMR.

Intended audience: 

• Infectious disease specialists, clinical microbiologists, and physicians working in internal medicine, surgery, dermatology, and related disciplines
• Clinical pharmacists and pharmacologists involved in antimicrobial therapy
• Biomedical researchers and microbiology laboratory personnel engaged in bacteriophage or AMR-related research
• Public health professionals, epidemiologists, and antimicrobial resistance (AMR) program managers
• Postgraduate students and trainees in medicine, microbiology, biotechnology, public health, or related life sciences

Objectives:

By the end of this course, participants will be able to:

• Evaluate the role of phage therapy in healthcare systems, with emphasis on Georgia’s clinical model and international developments.
• Apply phage-based strategies to manage antibiotic-resistant infections in various clinical scenarios
• Evaluate current clinical evidence supporting phage therapy, including its use alongside conventional antimicrobial treatments.
• Design a preliminary treatment protocol or research plan incorporating phage therapy principles.
• Interpret phagograms and assess phage-host specificity for individualized treatment planning.

Course coordinator:

Tamar Didbaridze, Georgia

Organisers: 

Tbilisi State Medical University, Georgia

Accreditation:

ESCMID office will apply for EACCME accreditation. 
Each participant can only receive the number of credits according to actual participation in the event and upon completion of the feedback survey.

Certification:

Course organisers will monitor attendance. Only participants attending sessions will be able to receive the certification.

Course Venue:

TBD

Accommodation:

Accommodation is not included in the registration.

Registration details: 

Registration fees include full access to the course, coffee breaks, and lunches. Travel costs and accommodation are not included with either fee.

Downloads

• Programme

Registration Fees